JO
UTHR icon

John Overdeck’s United Therapeutics UTHR Stock Holding History

John Overdeck’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,900
Closed -$2.31M – 5456
2026
Q1 		$2.31M Buy
+3,900
New +$1.94M ﹤0.01% 2646
2022
Q1 		– Sell
-3,000
Closed -$648K – 4364
2021
Q4 		$648K Buy
+3,000
New +$589K ﹤0.01% 2993
2021
Q3 		– Sell
-3,000
Closed -$538K – 4742
2021
Q2 		$538K Buy
+3,000
New +$571K ﹤0.01% 3033
2020
Q2 		– Sell
-9,900
Closed -$939K – 3550
2020
Q1 		$939K Buy
9,900
+1,900
+24% +$181K 0.01% 1451
2019
Q4 		$705K Buy
8,000
+2,500
+45% +$220K ﹤0.01% 2514
2019
Q3 		$439K Buy
5,500
+1,500
+38% +$121K ﹤0.01% 2658
2019
Q2 		$312K Buy
4,000
+1,000
+33% +$93.5K ﹤0.01% 2842
2019
Q1 		$352K Buy
+3,000
New +$350K ﹤0.01% 2498
2018
Q4 		– Sell
-4,000
Closed -$512K – 3552
2018
Q3 		$512K Sell
4,000
-2,600
-39% -$322K ﹤0.01% 2432
2018
Q2 		$747K Sell
6,600
-7,500
-53% -$824K ﹤0.01% 2359
2018
Q1 		$1.58M Buy
14,100
+11,100
+370% +$1.41M 0.01% 1690
2017
Q4 		$444K Sell
3,000
-2,200
-42% -$280K ﹤0.01% 2519
2017
Q3 		$609K Buy
5,200
+3,600
+225% +$460K ﹤0.01% 2026
2017
Q2 		$208K Buy
+1,600
New +$200K ﹤0.01% 2791
2016
Q4 		– Sell
-3,000
Closed -$354K – 3541
2016
Q3 		$354K Buy
+3,000
New +$360K ﹤0.01% 2652
2016
Q1 		– Sell
-3,000
Closed -$470K – 3148
2015
Q4 		$470K Buy
+3,000
New +$437K ﹤0.01% 2000
2015
Q3 		– Sell
-3,000
Closed -$522K – 2768
2015
Q2 		$522K Buy
+3,000
New +$540K ﹤0.01% 2094

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

John Overdeck's UTHR Position: Q2 2026 in Review

John Overdeck reduced its United Therapeutics (UTHR) stake by 55% in Q2 2026, selling an estimated $8.54M and leaving 12,606 shares worth $6.83M. The position accounts for ﹤0.01% of the portfolio, ranked #1849.

John Overdeck first reported a position in UTHR in Q2 2013 and has held it in 46 quarters since. The position peaked at $52.4M in Q2 2019. 874 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • John Overdeck held 12,606 shares of United Therapeutics worth $6.83M as of Q2 2026.
  • John Overdeck sold 15,170 United Therapeutics shares in Q2 2026, an estimated $8.54M.
  • United Therapeutics made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #1849 holding.
  • John Overdeck first reported a position in United Therapeutics in Q2 2013 and has held it in 46 quarters since.
  • John Overdeck's United Therapeutics position peaked at $52.4M in Q2 2019.
  • 874 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.